SGLT2i and GLP1-RA exert additive cardiorenal protection with a RAS blocker in uninephrectomized db/db mice.
Martos-Guillami N, Vergara A, Llorens-Cebrià C, Motto AE, Martínez-Díaz I, Gonçalves F, Garcias-Ramis MM, Allo-Urzainqui E, Narváez A, Bermejo S, Muñoz V, León-Román J, Ferrer-Costa R, Jacobs-Cachá C, Vilardell-Vilà J, Soler MJ.
Martos-Guillami N, et al. Among authors: munoz v.
Front Pharmacol. 2024 Oct 7;15:1415879. doi: 10.3389/fphar.2024.1415879. eCollection 2024.
Front Pharmacol. 2024.
PMID: 39434906
Free PMC article.